Clinical Trial Update: Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial sponsored by Bayer evaluates the safety and efficacy of a new chemotherapy agent for metastatic breast cancer; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• New Chemotherapy Agent

Snippet

Sponsor: Bayer | Conditions: Breast Neoplasms, Breast Cancer, Metastatic | Phase 2 | Status: COMPLETED